Myocardial texture characterization by two-dimensional echocardiography

Twenty-four normal subjects and 181 patients with various cardiac disorders (36 autopsies) were studied by 2-dimensional echocardiography. In vitro echocardiographic studies were performed on 26 of 36 autopsied hearts utilizing an ultrasonically visible metallic probe to correlate myocardial echo patterns with histopathologic features. All normal subjects and the majority of patients with ventricular hypertrophy due to valvular or hypertensive lesions showed a uniformly speckled or an echolucent appearance of the myocardium (type I texture). No autopsied heart with this texture had gross fibrosis (visible to the naked eye) or infiltrative disease. All patients with infiltrative disorders (amyloidosis, 7 of 7; Pompe's disease, 4 of 4) had multiple, discrete, and small (3 to 5 mm) highly refractile echoes (HREs) in the myocardium involving the ventricle or ventricles completely (type IIA texture) or partly (type IIB texture). However, this finding was non-specific and was observed in many other conditions such as left heart hypoplastic syndrome (10 of 10), hypertrophic cardiomyopathy (19 of 26), and chronic renal failure (4 of 9). In the noninfiltrative group, HREs in the autopsied cases were shown to result from gross fibrosis or endocardiofibroelastosis utilizing in vitro echocardiographic studies and metallic probe-guided biopsies, while HREs in the autopsied cases with cardiac amyloidosis could be correlated only with amyloid deposits since fibrosis was absent. Larger HREs (greater than 5 mm) presenting as broad patches or long linear echoes in the myocardium (type IIC texture) was seen in old myocardial infarctions (9 of 21) and congestive cardiomyopathy (4 of 26) and were correlated with large areas of myocardial fibrosis. Two-dimensional echocardiographic studies of myocardial texture help identify various infiltrative and degenerative processes in the heart.     

Single and two dimensional echocardiographic features of the interatrial septum in normal subjects and patients with an atrial septal defect.

The interatrial septum is one of the least studied structures in M mode echocardiography. Two dimensional echocardiography has made it possible to record simultaneous M mode and two dimensional echocardiograms. Such studies were performed in 10 normal subjects and in 9 patients with a secundum atrial septal defect. In the short axis view of the base of the heart, the interatrial septum was visualized in the two dimensional studies as a linear echo running from the posterior aortic wall to the posterior atrial wall and in the M mode records as a series of dense echoes posterior to the aorta. The great variability in echo dropout of the interatrial septum made it impossible to distinguish the normal subjects from the patients with atrial septal defect. The dense echoes of the interial septum in the M mode records gave the false impression that they were filling the left atrium. These data indicate that (1) a secundum atrial septal defect cannot be reliably differentiated from a normal septum using these echocardiographic methods, and (2) the medial location of the interatrial septum should be appreciated so that it will not be confused with a left atrial mass.     

Echocardiographic features of false tendons in the left ventricle

M mode and two dimensional echocardiographic features consistent with previously reported autopsy findings of false tendons were seen in 5 of approximately 1,000 consecutive echocardiographic examinations. Later, the presence of false tendon was proved at autopsy in one of the five cases. Examination in three cases revealed heart disease: aortic regurgitation, third degree atrioventricular (A-V) block with aortic regurgitation and invasive thymoma with pericardial effusion; examination in two cases revealed no heart disease.In three cases, M mode echocardiograms revealed in the outflow tract of the left ventricle abnormal linear echoes that strongly mimicked those in other disorders such as discrete subaortic stenosis or flail aortic valve. In two cases, there were abnormal linear echoes in the left ventricle toward the apex. In three cases, two dimensional echocardiograms revealed long string-like echoes stretching from the upper part of the interventricular septum across the ventricular cavity to the lateral wall of the left ventricle in long and short axis views or in four chamber views. In two cases, long slender echoes between the lower parts of the interventricular septum and the left ventricle were seen in apical long axis views. These string-like echoes seem to represent the false tendons previously reported only at autopsy, although actual pathologic confirmation was available in only one of the five cases.It is concluded that (1) M mode and two dimensional echocardiograms can demonstrate the presence of false tendons, and (2) two dimensional echocardiograms are useful in differentiating false tendons from other conditions causing abnormal linear echoes in the outflow tract of the left ventricle on M mode echography.     

Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients

In 30 of 1,002 consecutive patients who had left heart catheterization and cineangiography for evaluation of either ischemic heart disease or cardiomyopathy the electrocardiogram showed giant negative T waves (greater than 10 mm) associated with high QRS voltage (R wave greater than 26 mm in lead V₅ or the sum of the S wave in lead V₁ and the R wave in lead V₅ 35 mm or more) in the precordial leads despite absence of hypertension or significant coronary artery disease. In all 30 patients a characteristic spade-like configuration (concentric apical hypertrophy) was observed in the right anterior oblique ventriculogram at end-diastole as well as in the long axis two dimensional echocardiogram.The average apical thickness in these patients (24.8 ± 6.6 mm) was significantly greater than that in normal subjects (9.4 ± 3.1 mm) (P < 0.001) or in patients with hypertrophic obstructive cardiomyopathy (14.7 ± 5.0 mm) (P < 0.001). Values for both the mid anterior free wall thickness (13.9 ± 4.1 mm) and the mid posterior free wall thickness (14.3 ± 3.0 mm) were greater than values in normal subjects (8.9 ± 1.8 mm and 8.2 ± 2.0 mm, respectively) (P < 0.001). However, the ratio between the apical and the mid anterior free wall thickness in these 30 patients (1.86 ± 0.53) was significantly greater than the ratio in normal subjects (1.05 ± 0.24), patients with hypertrophic obstructive cardiomyopathy (0.96 ± 0.15) (P < 0.001) and patients with types of nonobstructive hypertrophic cardiomyopathy (1.26 ± 0.24) (P < 0.005) other than apical concentric hypertrophy. Obstruction of the tract did not occur because the upper half of the septem remained rather thin in systole and did not bulge into the left ventricle during systole. Pressure study with proper provocations as well as two dimensional echocardiograms revealed no peak systolic pressure gradient or obstruction within the outflow tract of the left ventricle.It is concluded that these 30 patients have nonobstructive hypertrophic cardiomyopathy with marked concentric hypertrophy in the apex (apical hypertrophic type) and with a different septal shape and contraction pattern from those seen in the obstructive type. This type of hypertrophy appears to be a fairly common type of hypertrophic cardiomyopathy in Japan.     

Expression of natriuretic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairment

Atrial natriuretic peptide (ANP) was immunohistochemically investigated in (1) right ventricular endomyocardial biopsy specimens from 87 apparently healthy donor hearts taken from victims of cerebral accidents; (2) 1 normal heart not suitable for transplantation (HBsAg carrier); (3) right ventricular endomyocardial biopsy specimens from 151 patients with dilated cardiomyopathy (DC); and (4) 57 explanted hearts, 26 with DC and 31 with ischemic heart disease. No ANP immunoreactivity was found in normal ventricles. Failing hearts showed ventricular positivity in 31% of the DC biopsy series, in 61% of the left ventricles, and in 30% of the right ventricles of the explanted heart series. An endoepicardial gradient was observed, because ANP positivity was greater and more extensive in the subendocardial layers. Ultrastructural studies were performed on biopsy specimens from 10 normal hearts and 132 DC biopsy samples. No ANP-storing granules were found in biopsy samples of normal ventricles, whereas ANP granules were seen in 15 of 132 (11.4%) DC cases. In parallel immunoblotting, investigation showed the same 13 kDa band protein in 1 normal atrium as well as in 8 failing atria and ventricles. ANP immunoreactivity was positively correlated with higher New York Heart Association functional classes as well as with higher left ventricular end-diastolic pressure (p less than 0.005), end-diastolic volume (p less than 0.005) and end-diastolic volume index (p less than 0.005). In conclusion, apparently healthy ventricles do not show ANP immunoreactivity, whereas failing ventricles do. ANP expression seems to be independent of the underlying disease, but positively related to the clinical status and the degree of left ventricular impairment and dilatation.     

Coronary embolus complicating peripartum cardiomyopathy

Peripartum cardiomyopathy is a rare disorder in which heart failure occurs during the last month of pregnancy or within 5 months of delivery, in the absence of any other etiology or prior heart disease. We present the case of a 42-year-old woman with peripartum cardiomyopathy. She was admitted with an acute myocardial infarction. Multiple mobile ventricular thrombi were seen in the echocardiogram. Coronary angiogram showed consequential coronary embolus occluding the left anterior descending artery. A successful embolectomy was performed followed by coronary stenting. There have been only two reports in the medical literature of coronary embolic events in the setting of peripartum cardiomyopathy; however, to our knowledge, we believe our case is the first to describe coronary intervention as treatment for the event.     

Two dimensional echocardiographic assessment of patients with bioprosthetic valves.

The clinical utility of two dimensional echocardiography in assessing bioprosthetic and left ventricular function was studied in 40 consecutive patients 1 week to 60 months after valve replacement surgery. These patients were referred to obtain normal baseline studies as well as to evaluate complications:suspected endocarditis, embolic phenomena and congestive heart failure of unknown cause. Independent M mode echocardiograms were also obtained in each patient. Confirmation of ultrasonic studies was by cardiac catheterization with angiography, surgery and pathologic study in 10 patients; cardiac catheterization with angiography alone in 7 patients; surgery and pathologic study in 3 patients; autopsy in 3 patients; blood cultures to confirm or exclude endocarditis in 10 patients; and confirmation on clinical grounds in 7 patients. Technically adequate two dimensional studies were recorded in 39 of 40 subjects. Two dimensional echocardiography accurately assessed 15 of 16 patients with an abnormal bioprosthetic valve and a normal left ventricle (1 of 16 patients had a false positive two dimensional echocardiogram); 8 of 8 patients suspected to have prosthetic valve or left ventricular dysfunction but who were normal; 7 of 7 patients with a normal prosthesis and an abnormal left ventricle; the one patient with an abnormal valve and left ventricle; and 7 of 7 clinically normal patients who were referred for baseline studies. In summary, the two-dimensional echocardiogram demonstrated a 97 percent diagnostic accuracy rate which was significantly greater than the 67 percent (P less than 0.001) for M mode echocardiography in the same group of patients. It is concluded that two dimensional echocardiography has excellent diagnostic accuracy in assessing bioprosthetic and left ventricular function and is superior to M mode echocardiography in evaluating patients after such valve replacement.     

Atrial natriuretic peptide distribution in fetal and failed adult human hearts

The distributions of atrial natriuretic peptide (ANP) in human hearts during the developmental stage and in adult pathological states was examined with an antibody specific to human alpha-ANP. With immunoblotting and immunofluorescence methods, we found that a 17-kDa protein, which is a pro ANP, was expressed in human fetal ventricles, in which the numbers of myofibers containing ANP granules were more abundant in the subendocardial region than the subepicardial region. As determined by radioimmunoassay, the content of immunoreactive ANP (per milligram protein) in the developing heart was greatest in the left atrium and occurred decreasingly in the right atrium, right ventricle, and left ventricle, respectively. Because ANP content in the left ventricle declined during the progress of gestation in developing hearts and because it was very low, if ever detectable, in normal adult hearts, ventricular ANP expression appears to be developmentally regulated from the early gestational stage. However, it was reexpressed in the ventricles of patients who had suffered from severe congestive heart failure. In this situation, we found that the ventricular ANP expression was more marked in patients with dilated cardiomyopathy than in patients with severe valvular disease. Interestingly, in the ventricles of patients with dilated cardiomyopathy, ANP contents were higher in the left ventricular free wall than in the right ventricular free wall, although the left ventricular subendocardium contained more ANP than the subepicardium, showing a transmural gradient similar to that expressed in fetal ventricles. Thus, the expression of ANP in human ventricles is developmentally regulated from the early gestational stage, and even adult ventricular myofibers can synthesize ANP during severe congestive heart failure.(ABSTRACT TRUNCATED AT 250 WORDS)     

Value of the floating catheter test in cardiologic diagnosis

This study had two aims: a) to investigate the diagnostic value of right heart catheterization at rest and during exercise in patients with angina pectoris and dyspnea, and b) to find out whether right heart catheterization during exercise provides additional diagnostic information when the correct diagnosis has been established by invasive means. The findings in 109 patients with coronary or myocardial heart disease (average age 50 years) were investigated retrospectively. Right heart catheterization is a semiinvasive measure which permits the differentiation of normal ventricles from ventricles with impaired function during exercise; further diagnostic information cannot be obtained, however. In patients with angina pectoris, right heart catheterization has no greater diagnostic value than the ECG during exercise. The patients were divided into five groups according to the final diagnosis: 55 with coronary heart disease, 11 with dilatative and 6 with latent cardiomyopathy, 26 with systemic hypertension, and 11 without heart disease. The results show that right heart catheterization during exercise is absolutely necessary in addition to invasive measures in patients with normal function of the left ventricle at rest and without coronary heart disease, as these patients show either a normal (patients with systemic hypertension, patients without heart disease) or an abnormal increase in pulmonary artery pressure during exercise (patients with systemic hypertension, patients with latent cardiomyopathy). Patients without coronary heart disease but with impaired left ventricular function even at rest always show a pathological increase in pulmonary artery pressure during exercise.(ABSTRACT TRUNCATED AT 250 WORDS)     

Radiofrequency catheter ablation for incessant atrioventricular nodal reentrant tachycardia normalized H-V block associated with tachycardia-induced cardiomyopathy

A 30-year-old man was admitted for treatment of tachycardia-induced cardiomyopathy caused by incessant atrioventricular nodal reentrant tachycardia (AVNRT). An echocardiogram revealed dilatation of all cardiac chambers with severe globally depressed biventricular systolic function. During an electrophysiologic study, HV interval was prolonged to 118 ms by atrial extrastimulus and 2:1 HV block was documented during AVNRT. Four weeks after catheter ablation for AVNRT, an echocardiogram demonstrated regression of the wall motion abnormality of both ventricles and of their dimensions. In the electrophysiologic study, the HV conduction disturbance disappeared. So far, this is the first case in which tachycardia-induced cardiomyopathy was accompanied by transient His-Purkinje conduction abnormality.     

A rare case of biventricular non-compaction associated with ventricular septal defect and descendent aortic stenosis in a young man.

Non-compaction of the ventricular myocardium is a cardiomyopathy caused by the arrest of normal embryogenesis of the ventricles. It is classified in isolated non-compaction of the ventricles (most frequently of the left one) and in ventricular non-compaction associated with other congenital anomalies of the endocardium and myocardium, such as obstruction of the right or left ventricular outflow tracts, complex cyanotic congenital heart disease, and coronary artery anomalies. There are controversies regarding the right ventricle non-compaction due to the normally trabeculated shape of its walls.We present a case of severe heart failure with a complex anomaly: biventricular non-compaction, ventricular septal defect and aortic thoracic stenosis.     

Restrictive cardiomyopathy following acute myocarditis--a case report

A fifty-five-year-old man developed intractable heart failure four weeks after upper respiratory infection. His central venous pressure was as high as 300 mmH2O. Two-dimensional echocardiogram revealed no muscular hypertrophy of the ventricles, no pericardial thickness, and no pericardial effusion. On catheterization, hemodynamic data were compatible with restrictive cardiomyopathy. Transvenous endomyocardial biopsy of the left ventricle was performed. Histologic examination strongly suggested that cardiomyopathy developed after acute myocarditis.     

Left ventricular isovolumic relaxation time estimated by the aortic root echocardiogram

Dual echocardiogram was recorded simultaneously with phonocardiogram (PCG) to analyze the isovolumic relaxation time (IRT) of the left ventricle (LV) in 85 patients with various heart diseases and in 23 normal subjects. The measurements used were time intervals from the onset of the aortic component of the second heart sound (IIA) to the onset of the posterior deflection of the posterior aortic wall in the aortic root echocardiogram (X) (IIA-X interval), and to the onset of the most rapid opening motion of the anterior mitral leaflet (D') (IIA-D' interval) during early diastole. 1. The IIA-X interval was directly proportional to the IIA-D' interval in the entire study population. 2. The IIA-X interval was prolonged with advancing age in normal subjects. 3. The IIA-X interval was significantly increased in patients with hypertensive heart disease, old myocardial infarction, hypertrophic cardiomyopathy, and dilated cardiomyopathy, but significantly decreased in patients with mitral stenosis. Thus, the IIA-X interval, which was measured easily and noninvasively from the aortic root echocardiogram is a reliable indicator of the isovolumic relaxation time of the left ventricle, as well as of the IIA-D' interval.     

Arrhythmogenic right ventricular cardiomyopathy with an initial manifestation of severe left ventricular impairment and normal contraction of the right ventricle

A case of arrhythmogenic right ventricular cardiomyopathy (ARVC) with an initial manifestation of severe impairment of the left ventricle (LV) and normal contraction of the right ventricle (RV) is presented. A 43-year-old man was admitted to hospital because of congestive heart failure following a common cold. The LV function was diffusely and severely hypokinetic. Coronary arteriogram revealed normal vessels. An endomyocardial biopsy specimen obtained from the RV septum revealed mild infiltration of lymphocytes with focal myocytes necrosis and so healing myocarditis was suspected. The specimen did not include any fatty replacement of myocytes. Since then, the patient suffered from recurrent congestive heart failure as well as nonsustained ventricular tachycardia and required frequent hospitalization. Progressive impairment, dilation, and thinning of both ventricles were observed on serial echocardiographic examinations. Although the RV gradually enlarged and became impaired, severe dilatation and impairment of the LV has always been predominant in the patient's clinical course. After medical follow-up for 10 years, he died suddenly of ventricular fibrillation and pump failure. The autopsy revealed extensive fibrofatty replacement of myocytes in both the ventricles, extending from the outer layer to the inner layer of myocardium in the RV and to the middle layer in the LV. These features were compatible with arrhythmogenic right ventricular cardiomyopathy or perimyocarditis, although only the rightsided bundle of the interventricular septum was completely replaced by fatty tissue, which can not be explained as a sequel of perimyocarditis. Moreover, apoptosis was present in the myocyte nuclei of the myocardial layers bordering the area of fatty replacement. Therefore, myocarditis may have triggered or accelerated the process of apoptosis leading to ARVC.     

Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy

To determine whether technetium-99m-pyrophosphate (Tc-99m-PYP) scanning or two-dimensional echocardiography can detect amyloid heart disease in an earlier stage of familial amyloid polyneuropathy, 15 patients were examined. Although 10 of the 15 patients had no clinical evidence of congestive heart failure, as well as normal ventricular wall thickness and normal values for left ventricular systolic function, five (50%) of them showed mild or moderate myocardial uptake. On the other hand, none had characteristic highly refractile myocardial echoes on the two-dimensional echocardiographic images (p less than 0.01), and values for diastolic function were reduced in four of the five and normal in the remaining one. In 85 control subjects, diffuse positive pyrophosphate scans of the heart were found in four (5%) of them (three with dilated cardiomyopathy and one with sarcoidosis), and highly refractile granular sparkling echoes were observed in nine (11%) (five with hypertrophic cardiomyopathy, three with aortic stenosis, and one with hypereosinophilic syndrome). We conclude that Tc-99m-PYP scanning is a more sensitive and specific method and may have the potential ability to detect amyloid heart disease in the earlier stage of familial amyloid polyneuropathy than two-dimensional echocardiography.     

Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice

The physiologic function of the progressive hyperleptinemia of diet-induced obesity is unknown. However, that lipotoxicity in nonadipose tissues of congenitally unleptinized obese rodents is far greater than in hyperleptinemic diet-induced obesity rodents has suggested an antilipotoxic role. To test this hypothesis, mice with severe lipotoxic cardiomyopathy, induced transgenically by cardiomyocyte-specific overexpression of the acyl CoA synthase (ACS) gene, were made hyperleptinemic by treatment with recombinant adenovirus containing the leptin cDNA. Normoleptinemic control ACS-transgenic mice developed severe dilated cardiomyopathy with thickened left ventricular walls and profound impairment of systolic function on echocardiogram; histologically, there was severe myofiber disorganization and interstitial fibrosis, with intracytoplasmic lipid vacuoles identifiable by electron microscope. By contrast, the hearts of hyperleptinemic ACS-transgenic mice appeared normal, with normal echocardiograms and cardiac triglyceride (TG) contents. Their lower myocardial TG content was ascribed primarily to profound lowering of plasma TG and free fatty acids; free fatty acids were 17% of normal at 8 weeks. Additionally, enhanced myocardial AMP-activated protein kinase phosphorylation may have increased fatty acid oxidation, thereby contributing to the lowering of lipid stores. We conclude that obesity-level hyperleptinemia protects the heart from lipotoxicity.     

回顾性调查线粒体疾病患者的心脏病变

目的 分析线粒体疾病心脏受累的表现,提高对该病的认识.方法 回顾北京协和医院20年来诊断的90例线粒体疾病患者临床与病理资料,包括心电图、动态心电图和心脏超声检查.结果 90例线粒体疾病患者中合并心脏病变29例.其中合并心肌病变5例(5.6%),为左心室肥厚2例、心脏扩大伴心力衰竭3例;合并先天性结构性心脏病4例(4.4%),包括三尖瓣或(和)二尖瓣脱垂各1例,房间隔或室间隔缺损各1例;各种不同程度心律失常20例(22.2%),包括安装永久起搏器者4例(3例在安装起搏器后1～3年才诊断为线粒体疾病),多种心律失常包括室性心动过速1例,阵发性房性心动过速1例,无症状的心律失常14例(分别是右束支传导阻滞4例,右束支合并左前分支传导阻滞1例,短PR间期综合征5例,B型预激综合征2例,室内传导阻滞2例).心脏传导阻滞在Kearns-Sayre综合征(9例)中发生率高达66.7%.8例患者检出线粒体基因A3243G突变.结论 线粒体疾病可以心肌病、心力衰竭、恶性心律失常为首发表现,对青壮年心肌病、伴发严重的心脏传导阻滞应尽可能寻找病因包括进行相关基因检查.此外,对所有诊断为线粒体疾病患者需定期进行心电图和超声心动图等检查以便尽早发现异常及早处理以改善预后.     

Relationship between heart rate and rhythm, and cardiac performance assessed in the human fetus in utero

To evaluate the relationship between heart rate and rhythm, and cardiac performance, in the human fetus in utero, observed over a long-term period in gestation, we made a total of 138 studies in 114 fetuses from 18 to 41 weeks of gestation; 104 having heart rate changes without rhythm disturbances ("control group"), 6 with complete atrioventricular block and 4 with supraventricular tachycardia. Using M-mode echocardiogram, we measured end-diastolic dimension and fractional shortening in the right and left ventricles. The corresponding heart rate for each cardiac cycle was measured using the interval between two consecutive end-systolic points. In fetuses in the group of controls, the values for fractional shortening in both ventricles were almost constant with advancing gestational age, unrelated to an increase in end-diastolic dimensions of either ventricle. There was no correlation between changes in heart rate and changes in the value of ventricular fractional shortening at any period of gestation studied. In the fetuses with atrioventricular block, dimensions and fractional shortenings in both ventricles were significantly larger than those in the group of control fetuses at the same stage of gestation. This indicates that the fetal heart is capable of acclimatizing itself, beginning as early as 18-25 weeks of gestation, to long-lasting bradycardia in which an increased stroke volume would be required. In fetuses with supraventricular tachycardia, end-diastolic dimensions were larger and fractional shortening was significantly smaller in both ventricles than in fetuses from the control group from 26-30 weeks of gestation onwards. This suggests tachycardia-induced cardiomyopathy occurring during intrauterine life.     

Intra-atrial smoke-like echoes and thrombi formation

Between December 1980 and December 1987, approximately 6,000 two-dimensional echocardiographic examinations were performed in our noninvasive cardiac laboratory. During this period, five cases of intra-atrial smoke-like echoes were diagnosed. The four patients with dense smoke-like echoes in the left atria all had echocardiographic evidence of severe mitral stenosis and thrombi in the left atrial cavity, both of which were confirmed at open-heart surgery. One patient with right-sided cardiomyopathy had echocardiographic evidence of dense smoke-like echoes and thrombus in the right atrial cavity. One of our five patients was receiving anticoagulant therapy, and none had a history of thromboembolism. We conclude that using conventional two-dimensional echocardiographic techniques, smoke-like echoes in the atria are a very infrequent finding and are very commonly associated with formation of thrombi.     

Echocardiographic discoveries in 102 patients with vascular cerebral accidents

The causes of vascular ischaemic accidents are numerous, and when the brain is involved management is limited to the prevention of similar events. Since cardiac sources of embolism potentially curable, we have prospectively analyzed the results of cardiovascular examinations (including ECG and radiography of the chest) and of echocardiography in 102 patients with cerebral or peripheral vascular ischaemic event in order to determine the impact of echocardiography and the influence of different diagnoses on the need for anticoagulant therapy. Intracardiac thrombi, mitral stenosis, dilated cardiomyopathy, severe left ventricular dysfunction with or without aneurysm and cardiac valve vegetations were regarded as diseases carrying a high risk of embolism, the low risk diseases being mitral valve prolapse, mitral annulus calcification and isolated left atrial dilatation. Atrial fibrillation was treated separately, as it may be associated with several of the diseases listed above. We found 14 diseases with a high risk of embolism (14 p. 100) and 35 diseases with a low risk of embolism (34 p. 100). 10/91 patients with cerebral vascular accident (11 p. 100) and 4/11 patients with peripheral vascular accident presented with a heart disease carrying a high risk of embolism. The most common heart disease with a high risk of embolism (10/14, 71 p. 100) was severe left ventricular dysfunction secondary to a coronary disease or a dilated cardiomyopathy. We did not find more cases of mitral valve prolapse or mitral annulus calcification than in the normal population. 20/29 patients with normal cardiac examination had a normal echocardiogram. The anticoagulant treatment was modified after echocardiography in only one case.(ABSTRACT TRUNCATED AT 250 WORDS)